Proprius Pharma Raises Series A

Proprius Pharmaceuticals Inc., a San Diego-based drug developer focused on rheumatology and autoimmune diseases, has raised $11 million in Series A funding (with an option to expand up to $17 million). Atlas Venture led the deal, and was joined by Forward Ventures, CDIB BioScience Venture Management and returns backers Fog City Fund and Windamere Venture Partners. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />